CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Loading organization profile…

Anonymous aggregate analytics use the connection IP transiently only to derive country; the IP is not stored in analytics data. DNT and GPC are honored, with 90-day retention. IP Geolocation by DB-IP.

Neuroscience Research Australia - Medical Cannabis Research Engine

CANNABISHUB:EUMedical cannabis research platform

conditions cannabinoids studies medicines library about

Organizations/facility

facility organization

Neuroscience Research Australia

AU

OPENALEX: I83657090↗ROR: 01g7s6g79↗

People

Connected researchers

Anna WaterreusORCID 0000-0002-1648-7701 Assen JablenskyORCID 0000-0003-0602-6810 Jan CopelandORCID 0000-0002-6525-7929 Jim LagopoulosORCID 0000-0002-5684-8583 Johanna C. BadcockORCID 0000-0003-4629-2929 Leonora E. LongORCID 0000-0002-1759-4138 Lucy AlbertellaORCID 0000-0001-5232-6414 Rose ChesworthORCID 0000-0002-3758-9598 Sally E. RookeExact authorship link Tim eKarlExact authorship link Tim KarlORCID 0000-0001-9904-8482 Vera A. MorganORCID 0000-0003-3600-9042

Public evidence

5 connected articles

Therapeutic properties of multi-cannabinoid treatment strategies for Alzheimer's disease.2022 · Europe PMC <i>In vivo</i> Evidence for Therapeutic Properties of Cannabidiol (CBD) for Alzheimer's Disease.2017 · Europe PMC Novel molecular changes induced by Nrg1 hypomorphism and Nrg1-cannabinoid interaction in adolescence: a hippocampal proteomic study in mice2013 · PubMed Central Open Access What does a mouse tell us about neuregulin 1—cannabis interactions?2013 · PubMed Central Open Access Distinct Neurobehavioural Effects of Cannabidiol in Transmembrane Domain Neuregulin 1 Mutant Mice2012 · PubMed Central Open Access

Matched by exact identifiers only. Profile data: OpenAlex.